To include your compound in the COVID-19 Resource Center, submit it here.

OvaRex MAb: Phase II

AXO said that in an open-label Phase II study of

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE